Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis
Abstract Breast cancer is the most common cancer in women both in the developed and less developed countries, and it imposes a considerable threat to human health. Therefore, in order to develop effective targeted therapies against Breast cancer, a deep understanding of its underlying molecular mech...
Main Authors: | Utkarsh Raj, Imlimaong Aier, Rahul Semwal, Pritish Kumar Varadwaj |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-03534-x |
Similar Items
-
An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma.
by: Imlimaong Aier, et al.
Published: (2019-01-01) -
Impact of artefact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data.
by: Thomas Samuel Carroll, et al.
Published: (2014-04-01) -
ChIPulate: A comprehensive ChIP-seq simulation pipeline.
by: Vishaka Datta, et al.
Published: (2019-03-01) -
ChIP-chip versus ChIP-seq: Lessons for experimental design and data analysis
by: Karchenko Peter V, et al.
Published: (2011-02-01) -
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
by: Pagès Hervé, et al.
Published: (2010-05-01)